Iron Bioavailability From Biofortified Orange-fleshed Sweet Potato
SASHA-II
SASHA-II Iron Bioavailability From Iron-biofortified Orange Fleshed Sweet Potato in Malawian Women Between 18-35 Years
1 other identifier
interventional
25
2 countries
2
Brief Summary
To combat iron deficiency in Low and Middle-Income Countries, sustainable food-based solutions have to be implemented to serve populations, not only individuals. One solution is the introduction of iron biofortified staple crops on market level. Before market level introduction, the bioavailability of iron in the new biofortified Orange Fleshed Sweet Potato (OFSP) breed needs to be assessed. In this study the investigator compares the fractional and total iron absorption after extrinsic stable isotope labelling of the new biofortified high iron OFSP variety and a normal market level OFSP variety. The study is conducted in Malawian women of reproductive age with marginal iron status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2019
CompletedFirst Posted
Study publicly available on registry
February 15, 2019
CompletedStudy Start
First participant enrolled
March 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2019
CompletedNovember 25, 2019
November 1, 2019
1 month
February 11, 2019
November 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fractional iron absorption from both Orange Fleshed Sweet Potato varieties
Proportion of stable isotope administered with test meals that has been incorporate into erythrocytes 14 days after completion of specific test meal feeding period
Measured 2 weeks after completion of feeding day sequence. Sequence consist of 2 times 10 feeding days.
Total iron absorption from both Orange Fleshed Sweet Potato varieties
Amount of iron absorbed (mg) from the labelled test meals
Measured 2 weeks after completion of feeding day sequence. Sequence consist of 2 times 10 feeding days.
Secondary Outcomes (2)
Concentration of plasma ferritin level
screening (-1), baseline (day 1), last test meal consumption (day 26) and 14 days after last test meal consumption (day 40)
Concentration of plasma CRP level
screening (-1), baseline (day 1), last test meal consumption (day 26) and 14 days after last test meal consumption (day 40)
Study Arms (2)
Orange Fleshed Sweet Potato High Iron
EXPERIMENTALMeal sequence B, OFSP High Fe
Orange Fleshed Sweet Potato Control
ACTIVE COMPARATORMeal sequence A, OFSP control
Interventions
400 gram steamed, mashed OFSP high Fe with 0.33 mg FeSO4-58 daily for 10 days
400 gram steamed, mashed OFSP control with 0.33 mg FeSO5-57 daily for 10 days
Eligibility Criteria
You may qualify if:
- Woman aged 18-35 years old
- low/marginal iron status respectively evidenced by one of the following criteria: PF ≤ 25 µg/L
- Normal BMI for age (18.5-25.0 kg/m2)
- Weight less than 65 kg. A maximum weight limitation is needed since the stable isotope portions are based on body weight. We want to give equal amounts of stable isotopes to each study participant and therefore need to standardize body weight.
- Living in a study radius of 30 km from the meal distribution/ health centre side
- Willing and able to commute to the set meal distribution/ health centre side
- Able to understand and to sign\* written concept prior to trial entry
- Informed consent signed \* Signing of informed consent by either autograph or finger print.
You may not qualify if:
- Severe anaemia Hb \<80 g/l
- High infection rate based on CRP \> 5 mg/L
- Any known chronic diseases
- Relevant digestive (intestinal, gastric, hepatic or pancreatic), renal, metabolic disease, as determined by the screening visit and by self-report from the subjects.
- Diagnosed food allergy.
- Pregnancy (urine test during screening
- Lactation.
- History of cancer within the past year, from self-report by the woman or as obtained from her health passport
- Any medication or supplement which may impact erythrocytes, Hb or haematocrit (to the opinion of the investigator).
- Iron supplementation therapy or perfusion in the last three months
- Significant blood losses over the past 6 months (i.e. trauma, major surgery, blood donation or other cause influencing blood volume to be investigated by the PI)
- Have a high alcohol consumption (more than 2 drinks/day).
- Consumption of illicit drugs based on reported use (based on anamnesis only).
- Subject having a hierarchical link with the investigator or co-investigators.
- Fever (body temperature \>37.5 °C), on day 1 of the feeding scheme
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Swiss Federal Institute of Technologylead
- University of Malawicollaborator
Study Sites (2)
Training and Research Unit of Excellence, University of Malawi
Zomba, Malawi
Swiss Federal Institute of Technology, Laboratory of Human Nutrition
Zurich, Canton of Zurich, 8092, Switzerland
Related Publications (1)
Jongstra R, Mwangi MN, Burgos G, Zeder C, Low JW, Mzembe G, Liria R, Penny M, Andrade MI, Fairweather-Tait S, Zum Felde T, Campos H, Phiri KS, Zimmermann MB, Wegmuller R. Iron Absorption from Iron-Biofortified Sweetpotato Is Higher Than Regular Sweetpotato in Malawian Women while Iron Absorption from Regular and Iron-Biofortified Potatoes Is High in Peruvian Women. J Nutr. 2020 Dec 10;150(12):3094-3102. doi: 10.1093/jn/nxaa267.
PMID: 33188398DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Zimmermann, Prof.
Swiss Federal Institute of Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participant is blinded, meal option A --\> B or B --\> A based on investigator randomisation.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2019
First Posted
February 15, 2019
Study Start
March 25, 2019
Primary Completion
May 3, 2019
Study Completion
May 3, 2019
Last Updated
November 25, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share